Matthieu Legrand

Critical care doc/Intensivist & Anesthesiologist - Prof @UCSF #criticalcare #AKI #sepsis #Translational #Trials

[Matthieu Legrand @matthieulegrand]

@giovannilandoni @SRAnesthesiaICU @MRE_signavitae @GiacomoMonti @KhannaAshishCCM @JCVAonline @AirwayMxAcademy @RobertoBurioni @CritCareReviews @CStoppe @DiegoPalumbo89 @iceman_ex @SFresilli @fabiodoc64 @fabio_taccone @gudokunst @Paul_Wischmeyer @nickmmark @PPallavicini @OrlandoRPN @MarcVives13 @YukiKotani5 👏👏

[France tv @FranceTV]

"Papa ne reviendra pas, il va falloir continuer sans lui."

Juliette avait 11 ans quand son père a été tué dans l'attentat du Bataclan. 10 ans plus tard, elle se souvient de ce moment tragique et livre un témoignage bouleversant dans le documentaire "13 Novembre - Les Ricochets"

[Alice Cordier @CordierAlice2]

Ne jamais oublier qui a fait le Bataclan et au nom de qui et de quoi.

Ne surtout pas oublier.

[Matthieu Legrand @matthieulegrand]

@IM_Crit_ This is not what is said in this editorial. What is written is: 1) liberal fluid ⬇️ AkI in abdominal surgery 2) amino-acids⬇️in cardiac surgery

[Matthieu Legrand @matthieulegrand]

yes+++

[IMCrit @IM_Crit_]

(Basic) ICU Hemodynamic “Secrets” - Part1:

I know you know them, but let’s remind ourselves of some basic hemodynamic "secrets":

[IMCrit @IM_Crit_]

(Basic) ICU Hemodynamic “Secrets” - Part1:

I know you know them, but let’s remind ourselves of some basic hemodynamic "secrets":

[ATS Blue Journal @ATSBlueEditor]

Iloprost for the Treatment of Severe Septic Shock with Persistent Hypoperfusion: A Double-Blind, Randomized Controlled Trial

In patients with septic shock and persistent hypoperfusion, iloprost did not reduce organ failure
@matthieulegrand

🔗 https://t.co/VOXAZRJ6D4

[ATS Blue Journal @ATSBlueEditor]

The Blue Journal thanks François Dépret, MD, PhD, for his contribution to the July issue

Iloprost for the Treatment of Severe Septic Shock with Persistent Hypoperfusion: A Double-Blind, Randomized Controlled Trial
@matthieulegrand

https://t.co/70w97sAYUx

[Critical Care Reviews @CritCareReviews]

Iloprost for the Treatment of Severe Septic Shock with Persistent Hypoperfusion: A Double-Blind, Randomized Controlled Trial

CCR Journal Watch - tracking the critical care literature daily
https://t.co/Sp06oA6IDG

[ATS Blue Journal @ATSBlueEditor]

Join AJRCCM, JAMA, and NEJM at “Discussions on the Edge” on Monday, May 19

Session B2. Pulmonary
9:15 a.m. Room 25 Hall E (North Building, Exhibition Level), Moscone Center
Session B92. Critical Care
2:15 p.m. Room 25 Hall E (North Building, Exhibition Level), Moscone Center

[ANZICS @anzics]

Dear friends and colleagues,

It is with overwhelming sadness that we share news of the death of our colleague, mentor and friend, Rinaldo Bellomo. During recent days, both he and his family have received dedicated, expert and compassionate care from some of the finest in our ICU community. We share their pain and sense of loss.

Over several decades, Rinaldo has made a profound and enduring impact on ICU practice in Australia, New Zealand and around the world. As a passionate researcher he challenged conventions, championed evidence-based practice in the care of the critically ill and supported countless colleagues in their research careers. As a compassionate mentor, colleague and friend, he touched and enriched numerous lives, and will be greatly missed. His loss will affect our whole community and in due course there will be opportunities to come together to celebrate his life.

This will be a difficult time for many, but we know that our memories of Rinaldo’s relentless enthusiasm, warmth, optimism and boundless energy will help us all through the weeks ahead. In lieu of flowers, Rinaldo's family would welcome donations to support his research legacy at https://t.co/29kO6OeHxe

Our sincere condolences and best wishes go out to his family, friends and colleagues.

Craig Carr, on behalf of the ANZICS community

[Matthieu Legrand @matthieulegrand]

@anzics We lost a giant. Rinaldo had a massive impact on so many of us—he was a true role model. Rinaldo will be deeply missed. My sincere condolences to his family and friends.

[Matthieu Legrand @matthieulegrand]

Postoperative Outcomes Among Sodium-Glucose Cotransporter 2 Inhibitor Users. What are the impart of SGLT2 inhibitors on postoperative outcomes? What are the risk of euglycemic keto-acidosis in patients treated with SGLT2 inhibitors and undergoing surgery? https://t.co/WLKC3S10Jk

[Matthieu Legrand @matthieulegrand]

@WashUanesthesia @BetaTallarico @JAMASurgery congrats Roberta! Well done!

[ISICEM @ISICEM]

ISICARE - In response to numerous requests last week, we’ve decided to extend this special offer for an additional week, until the end of the early bird rate, March 31!
Register now & take advantage of this unique opportunity!
https://t.co/tXH9pGpQuX
#ISICARE
@FilippoAnnoni4

[ISICEM @ISICEM]

#𝐈𝐒𝐈𝐂𝐄𝐌𝟐𝟓 – 𝐓𝐡𝐚𝐧�� 𝐘𝐨𝐮!
An incredible few days of learning, collaboration & innovation! Huge thanks to our attendees, speakers & partners—your dedication is inspiring.
The story continues… See you at #ISICEM26 or our next meetings!
#ICUcommunity #ISICEMers

[ISICEM @ISICEM]

Do you remember?
This week only, #ISICEM25 attendees can enjoy an exclusive extra discount on the early bird registration for our brand-new #ISICARE congress!
🎥 Watch now as Prof. Filippo Annoni shares more details!
🔗 Register now: https://t.co/tXH9pGpQuX

[Michael Avidan @avidan_michael]

Some people have asked for full text access to my essay titled, Making Time - A Meta Static Journey. Here is a link: https://t.co/jqQ5Ap6Ax8

[Matthieu Legrand @matthieulegrand]

@avidan_michael 🙏❤️

[Matthieu Legrand @matthieulegrand]

@KhannaAshishCCM HI Ashish. No